Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
In individuals with allergic rhinitis, the immune system overreacts and causes an allergic reaction when allergens such as pollen, mold, and dander come in contact with the immune system.
The global Allergic Rhinitis Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Allergic Rhinitis Drugs in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy and Online
Pharmacy,, are propelling Allergic Rhinitis Drugs market. Antihistamines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intranasal Corticosteroids segment is estimated at % CAGR for the next seven-year period.
The Americas accounted for the major shares of the allergy rhinitis drugs market during 2016. In the Americas, the US accounted for a major share and this attribute to factors such as the growing prevalence of infectious diseases, especially allergy rhinitis in the country.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Allergic Rhinitis Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Allergic Rhinitis Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Allergic Rhinitis Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Allergic Rhinitis Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Allergic Rhinitis Drugs covered in this report include GlaxoSmithKline, Sanofi, ALK-Abelló, Meda Pharmaceuticals, Adamis Pharmaceuticals, Allergy Therapeutics, Almirall, Ampio and AstraZeneca, etc.
The global Allergic Rhinitis Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Global Allergic Rhinitis Drugs market, by region:
Global Allergic Rhinitis Drugs market, Segment by Type:
Global Allergic Rhinitis Drugs market, by Application
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Allergic Rhinitis Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Allergic Rhinitis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Allergic Rhinitis Drugs Market Overview
1.1 Allergic Rhinitis Drugs Product Overview
1.2 Allergic Rhinitis Drugs Market Segment by Type
1.2.1 Antihistamines
1.2.2 Intranasal Corticosteroids
1.2.3 Immunotherapies
1.3 Global Allergic Rhinitis Drugs Market Size by Type
1.3.1 Global Allergic Rhinitis Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Allergic Rhinitis Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Allergic Rhinitis Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Allergic Rhinitis Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Allergic Rhinitis Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Allergic Rhinitis Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Allergic Rhinitis Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Allergic Rhinitis Drugs Sales Breakdown by Type (2018-2023)
2 Global Allergic Rhinitis Drugs Market Competition by Company
2.1 Global Top Players by Allergic Rhinitis Drugs Sales (2018-2023)
2.2 Global Top Players by Allergic Rhinitis Drugs Revenue (2018-2023)
2.3 Global Top Players by Allergic Rhinitis Drugs Price (2018-2023)
2.4 Global Top Manufacturers Allergic Rhinitis Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Allergic Rhinitis Drugs Market Competitive Situation and Trends
2.5.1 Allergic Rhinitis Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Allergic Rhinitis Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Allergic Rhinitis Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Allergic Rhinitis Drugs Market
2.8 Key Manufacturers Allergic Rhinitis Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Allergic Rhinitis Drugs Status and Outlook by Region
3.1 Global Allergic Rhinitis Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Allergic Rhinitis Drugs Historic Market Size by Region
3.2.1 Global Allergic Rhinitis Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Allergic Rhinitis Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Allergic Rhinitis Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Allergic Rhinitis Drugs Forecasted Market Size by Region
3.3.1 Global Allergic Rhinitis Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Allergic Rhinitis Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Allergic Rhinitis Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Allergic Rhinitis Drugs by Application
4.1 Allergic Rhinitis Drugs Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Allergic Rhinitis Drugs Market Size by Application
4.2.1 Global Allergic Rhinitis Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Allergic Rhinitis Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Allergic Rhinitis Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Allergic Rhinitis Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Allergic Rhinitis Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Allergic Rhinitis Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Allergic Rhinitis Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Allergic Rhinitis Drugs Sales Breakdown by Application (2018-2023)
5 North America Allergic Rhinitis Drugs by Country
5.1 North America Allergic Rhinitis Drugs Historic Market Size by Country
5.1.1 North America Allergic Rhinitis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Allergic Rhinitis Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Allergic Rhinitis Drugs Sales in Value by Country (2018-2023)
5.2 North America Allergic Rhinitis Drugs Forecasted Market Size by Country
5.2.1 North America Allergic Rhinitis Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Allergic Rhinitis Drugs Sales in Value by Country (2024-2029)
6 Europe Allergic Rhinitis Drugs by Country
6.1 Europe Allergic Rhinitis Drugs Historic Market Size by Country
6.1.1 Europe Allergic Rhinitis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Allergic Rhinitis Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Allergic Rhinitis Drugs Sales in Value by Country (2018-2023)
6.2 Europe Allergic Rhinitis Drugs Forecasted Market Size by Country
6.2.1 Europe Allergic Rhinitis Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Allergic Rhinitis Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Allergic Rhinitis Drugs by Region
7.1 Asia-Pacific Allergic Rhinitis Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Allergic Rhinitis Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Allergic Rhinitis Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Allergic Rhinitis Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Allergic Rhinitis Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Allergic Rhinitis Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Allergic Rhinitis Drugs Sales in Value by Region (2024-2029)
8 Latin America Allergic Rhinitis Drugs by Country
8.1 Latin America Allergic Rhinitis Drugs Historic Market Size by Country
8.1.1 Latin America Allergic Rhinitis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Allergic Rhinitis Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Allergic Rhinitis Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Allergic Rhinitis Drugs Forecasted Market Size by Country
8.2.1 Latin America Allergic Rhinitis Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Allergic Rhinitis Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Allergic Rhinitis Drugs by Country
9.1 Middle East and Africa Allergic Rhinitis Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Allergic Rhinitis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Allergic Rhinitis Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Allergic Rhinitis Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Allergic Rhinitis Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Allergic Rhinitis Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Allergic Rhinitis Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Allergic Rhinitis Drugs Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Allergic Rhinitis Drugs Products Offered
10.2.5 Sanofi Recent Development
10.3 ALK-Abelló
10.3.1 ALK-Abelló Company Information
10.3.2 ALK-Abelló Introduction and Business Overview
10.3.3 ALK-Abelló Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 ALK-Abelló Allergic Rhinitis Drugs Products Offered
10.3.5 ALK-Abelló Recent Development
10.4 Meda Pharmaceuticals
10.4.1 Meda Pharmaceuticals Company Information
10.4.2 Meda Pharmaceuticals Introduction and Business Overview
10.4.3 Meda Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Meda Pharmaceuticals Allergic Rhinitis Drugs Products Offered
10.4.5 Meda Pharmaceuticals Recent Development
10.5 Adamis Pharmaceuticals
10.5.1 Adamis Pharmaceuticals Company Information
10.5.2 Adamis Pharmaceuticals Introduction and Business Overview
10.5.3 Adamis Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Adamis Pharmaceuticals Allergic Rhinitis Drugs Products Offered
10.5.5 Adamis Pharmaceuticals Recent Development
10.6 Allergy Therapeutics
10.6.1 Allergy Therapeutics Company Information
10.6.2 Allergy Therapeutics Introduction and Business Overview
10.6.3 Allergy Therapeutics Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Allergy Therapeutics Allergic Rhinitis Drugs Products Offered
10.6.5 Allergy Therapeutics Recent Development
10.7 Almirall
10.7.1 Almirall Company Information
10.7.2 Almirall Introduction and Business Overview
10.7.3 Almirall Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Almirall Allergic Rhinitis Drugs Products Offered
10.7.5 Almirall Recent Development
10.8 Ampio
10.8.1 Ampio Company Information
10.8.2 Ampio Introduction and Business Overview
10.8.3 Ampio Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Ampio Allergic Rhinitis Drugs Products Offered
10.8.5 Ampio Recent Development
10.9 AstraZeneca
10.9.1 AstraZeneca Company Information
10.9.2 AstraZeneca Introduction and Business Overview
10.9.3 AstraZeneca Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 AstraZeneca Allergic Rhinitis Drugs Products Offered
10.9.5 AstraZeneca Recent Development
10.10 Amneal Pharmaceuticals
10.10.1 Amneal Pharmaceuticals Company Information
10.10.2 Amneal Pharmaceuticals Introduction and Business Overview
10.10.3 Amneal Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Amneal Pharmaceuticals Allergic Rhinitis Drugs Products Offered
10.10.5 Amneal Pharmaceuticals Recent Development
10.11 Anergis
10.11.1 Anergis Company Information
10.11.2 Anergis Introduction and Business Overview
10.11.3 Anergis Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Anergis Allergic Rhinitis Drugs Products Offered
10.11.5 Anergis Recent Development
10.12 Apotex
10.12.1 Apotex Company Information
10.12.2 Apotex Introduction and Business Overview
10.12.3 Apotex Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Apotex Allergic Rhinitis Drugs Products Offered
10.12.5 Apotex Recent Development
10.13 Array BioPharma
10.13.1 Array BioPharma Company Information
10.13.2 Array BioPharma Introduction and Business Overview
10.13.3 Array BioPharma Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Array BioPharma Allergic Rhinitis Drugs Products Offered
10.13.5 Array BioPharma Recent Development
10.14 Aspen Pharmacare
10.14.1 Aspen Pharmacare Company Information
10.14.2 Aspen Pharmacare Introduction and Business Overview
10.14.3 Aspen Pharmacare Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Aspen Pharmacare Allergic Rhinitis Drugs Products Offered
10.14.5 Aspen Pharmacare Recent Development
10.15 Circassia Pharmaceuticals
10.15.1 Circassia Pharmaceuticals Company Information
10.15.2 Circassia Pharmaceuticals Introduction and Business Overview
10.15.3 Circassia Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Circassia Pharmaceuticals Allergic Rhinitis Drugs Products Offered
10.15.5 Circassia Pharmaceuticals Recent Development
10.16 Dr Reddy's Laboratories
10.16.1 Dr Reddy's Laboratories Company Information
10.16.2 Dr Reddy's Laboratories Introduction and Business Overview
10.16.3 Dr Reddy's Laboratories Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Dr Reddy's Laboratories Allergic Rhinitis Drugs Products Offered
10.16.5 Dr Reddy's Laboratories Recent Development
10.17 Eddingpharm
10.17.1 Eddingpharm Company Information
10.17.2 Eddingpharm Introduction and Business Overview
10.17.3 Eddingpharm Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Eddingpharm Allergic Rhinitis Drugs Products Offered
10.17.5 Eddingpharm Recent Development
10.18 EMS
10.18.1 EMS Company Information
10.18.2 EMS Introduction and Business Overview
10.18.3 EMS Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.18.4 EMS Allergic Rhinitis Drugs Products Offered
10.18.5 EMS Recent Development
10.19 HAL Allergy
10.19.1 HAL Allergy Company Information
10.19.2 HAL Allergy Introduction and Business Overview
10.19.3 HAL Allergy Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.19.4 HAL Allergy Allergic Rhinitis Drugs Products Offered
10.19.5 HAL Allergy Recent Development
10.20 Inmunotek
10.20.1 Inmunotek Company Information
10.20.2 Inmunotek Introduction and Business Overview
10.20.3 Inmunotek Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Inmunotek Allergic Rhinitis Drugs Products Offered
10.20.5 Inmunotek Recent Development
10.21 Genentech
10.21.1 Genentech Company Information
10.21.2 Genentech Introduction and Business Overview
10.21.3 Genentech Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Genentech Allergic Rhinitis Drugs Products Offered
10.21.5 Genentech Recent Development
10.22 Greer Laboratories
10.22.1 Greer Laboratories Company Information
10.22.2 Greer Laboratories Introduction and Business Overview
10.22.3 Greer Laboratories Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.22.4 Greer Laboratories Allergic Rhinitis Drugs Products Offered
10.22.5 Greer Laboratories Recent Development
10.23 Glenmark Pharmaceuticals
10.23.1 Glenmark Pharmaceuticals Company Information
10.23.2 Glenmark Pharmaceuticals Introduction and Business Overview
10.23.3 Glenmark Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.23.4 Glenmark Pharmaceuticals Allergic Rhinitis Drugs Products Offered
10.23.5 Glenmark Pharmaceuticals Recent Development
10.24 Hanmi Pharmaceuticals
10.24.1 Hanmi Pharmaceuticals Company Information
10.24.2 Hanmi Pharmaceuticals Introduction and Business Overview
10.24.3 Hanmi Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.24.4 Hanmi Pharmaceuticals Allergic Rhinitis Drugs Products Offered
10.24.5 Hanmi Pharmaceuticals Recent Development
10.25 Hisamitsu Pharmaceutical
10.25.1 Hisamitsu Pharmaceutical Company Information
10.25.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.25.3 Hisamitsu Pharmaceutical Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.25.4 Hisamitsu Pharmaceutical Allergic Rhinitis Drugs Products Offered
10.25.5 Hisamitsu Pharmaceutical Recent Development
10.26 Intas Pharmaceuticals
10.26.1 Intas Pharmaceuticals Company Information
10.26.2 Intas Pharmaceuticals Introduction and Business Overview
10.26.3 Intas Pharmaceuticals Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.26.4 Intas Pharmaceuticals Allergic Rhinitis Drugs Products Offered
10.26.5 Intas Pharmaceuticals Recent Development
10.27 Novartis
10.27.1 Novartis Company Information
10.27.2 Novartis Introduction and Business Overview
10.27.3 Novartis Allergic Rhinitis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.27.4 Novartis Allergic Rhinitis Drugs Products Offered
10.27.5 Novartis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Allergic Rhinitis Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Allergic Rhinitis Drugs Industrial Chain Analysis
11.4 Allergic Rhinitis Drugs Market Dynamics
11.4.1 Allergic Rhinitis Drugs Industry Trends
11.4.2 Allergic Rhinitis Drugs Market Drivers
11.4.3 Allergic Rhinitis Drugs Market Challenges
11.4.4 Allergic Rhinitis Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Allergic Rhinitis Drugs Distributors
12.3 Allergic Rhinitis Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research